Nan Fung Trinity
CLYM icon

Nan Fung Trinity’s Climb Bio CLYM Stock Holding History

Nan Fung Trinity’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.14M Hold
360,654
– – 0.4% 49
2026
Q2 		$4.7M Sell
360,654
-59,863
-14% -$618K 0.46% 49
2026
Q1 		$2.88M Sell
420,517
-43,137
-9% -$249K 0.32% 55
2025
Q4 		$1.85M Hold
463,654
– – 0.15% 74
2025
Q3 		$932K Hold
463,654
– – 0.09% 67
2025
Q2 		$575K Buy
+463,654
New +$577K 0.07% 57

Other funds holding CLYM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Nan Fung Trinity's CLYM Position: Q3 2026 in Review

Nan Fung Trinity held its Climb Bio (CLYM) position steady in Q3 2026 at 360,654 shares worth $4.14M. The position accounts for 0.4% of the portfolio, ranked #49.

Nan Fung Trinity first reported a position in CLYM in Q2 2025 and has held it in 6 quarters since. The position peaked at $4.7M in Q2 2026. 37 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.

  • Nan Fung Trinity held 360,654 shares of Climb Bio worth $4.14M as of Q3 2026.
  • Nan Fung Trinity left its Climb Bio share count unchanged in Q3 2026.
  • Climb Bio made up 0.4% of Nan Fung Trinity's portfolio in Q3 2026, its #49 holding.
  • Nan Fung Trinity first reported a position in Climb Bio in Q2 2025 and has held it in 6 quarters since.
  • Nan Fung Trinity's Climb Bio position peaked at $4.7M in Q2 2026.
  • 37 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.

Based on Nan Fung Trinity's 13F filing for Q3 2026, filed 6 Nov 2026.